New antimicrobials through genomics and protein structure.
Rational drug design using protein structure analysis.
High throughput proteomics for novel therapeutics.
Mathematics and engineering to model biological systems.
Peptide based vaccines and novel drug candidates.
Cell signalling pathways in diabetes and metabolic disorders.
Developing cell based immunotherapy for cancer and other diseases.

Current MWC news

Page Index
  1.    Press releases
  2.    May 2010: Biology whizz wins top prize for T cell research
  3.    Nov 2009: New class of anti-cancer drugs unveiled
  4.    Nov 2009: Women in Science laureates’ team up to target cancer and ageing
  5.    Nov 2009: Professor Peter Hunter is awarded the Rutherford Medal, New Zeland's top science award
  6.    Apr 2009: MWC doctoral student wins inaugural fellowship to Cambrige University
  7.    Apr 2009: MWC student wins place at international symposium
  8.    Feb 2009: Peter Hunter receives KEA award
  9.    Aug 2008 New startup company receives significant funding
  10.    June 2008 MRC groups receive HRC funding
  11.    Feb 2008 MWC Scientists receive World Class awards
  12.    Dec 2007 MWC PhD student gets paper published in Science
  13.    Sep 2007 A new tool to predict the spread of melanoma
  14.    Sep 2007 Discoveries on immune evasion by Staph aureus
  15.    Jun 2007 MWC doctoral student in McDiarmid Young Scientist award
  16.    Director of the MWC awarded the prestigeous Rutherford Medal, the highest accolade in New Zealand Science
  17.    CMB student runner up to MacDiarmid Young Scientist of the Year
  18.    Prof. Peter Hunter elected to the Royal Society
  19.    A new type of anti-cancer drug

Press releases   


May 2010: Biology whizz wins top prize for T cell research   


From left Greg Hung, Joyce Ho, Jae-Kyung Hyun and Dr Anindito Sen

University of Auckland biology student Joyce Ho has wowed a judging panel of top international scientists with her research into the activation of human T cells.

Joyce, a third year PhD student at the School of Biological Sciences, won the prize for “Best overall research poster” at the Maurice Wilkins Centre’s poster competition on 22 April. She will receive $5,000 to spend on travel to either a science conference or to an international laboratory to learn new skills or techniques.

Joyce’s winning poster looks at the effects of cytokines called IL-12 and IL-21 on the activation of CD8+ T cells – a type of white blood cells that provide essential protection against viral infections and cancer. She and Dr Anna Brooks discovered that these cytokines promote the functions of “memory” CD8+ T cells.

Joyce explains the importance of these memory cells: “Each T cell recognises a certain shape, such as a type of flu virus. When these T cells are activated, they form a large number of cells to fight against the virus. Once the flu virus has died off, some of these T cells will stay in the body as memory cells. Next time you get that same flu virus, the memory cells will remember the virus and they will kill it much quicker.”

To carry out her research, Joyce helped to develop a new model for growing and activating T cells in the laboratory under the supervision of Maurice Wilkins Centre Director Associate Professor Rod Dunbar. Using this model, the team can now grow T cells to a memory stage. These memory T cells could one day be used to design effective vaccines and immunotherapy.

“My role is to work out how to make white blood cells function better, that is, to kill invaders such as viruses more effectively,” says Joyce.

Joyce says the competition was a great opportunity to present her work to top international scientists and listen to their feedback.

Jae-Kyung Hyun, a PhD student in Associate Professor Alok Mitra’s laboratory at the School of Biological Sciences, won a $1000 cash prize for “Best student poster”. Jae is studying the structure of capsid proteins found in retroviruses – a family of pathogenic viruses that can cause deadly diseases such as HIV-1. He is using the Rous sarcoma virus – a tumour-causing retrovirus in birds – as a model organism.

Maurice Wilkins Centre Research Manager Rochelle Ramsay says the competition was a great chance to showcase the research of Maurice Wilkins Centre investigators and their graduate students.

“The judges, who were in New Zealand for the centre’s Science Advisory Board meeting, were very impressed by the high standard of the posters. They found it hard to pick a winner.”

Highly commended awards went to Greg Hung, a PhD student in Professor Margaret Brimble’s laboratory at the Department of Chemistry, and to Dr Anindito Sen, a post-doctoral fellow in Associate Professor Alok Mitra’s laboratory.


Nov 2009: New class of anti-cancer drugs unveiled   

Medicinal chemist Dr. Jeffrey Smaill and cancer biologist Dr Adam Patterson, investigators with the Maurice Wilkins Centre for Molecular Biodiscovery, have just arrived back in New Zealand from the world’s premier conference for molecular targets and cancer therapeutics in Boston, US, where they announced the discovery of a new class of anti-cancer drugs.


Nov 2009: Women in Science laureates’ team up to target cancer and ageing   

Two L’Oréal-UNESCO Women in Science laureates (Prof. Margaret Brimble of MWC and Prof. Nacy Ip, University of Hong Kong) are joining forces to screen compounds that may shut down an enzyme that plays a major role in ageing and cancer. They have recently received funding from the NZ Foundation for Science and Technology for this international collaboration.


Nov 2009: Professor Peter Hunter is awarded the Rutherford Medal, New Zeland's top science award   

At a black tie dinner to celebrate the Royal Society of New Zealand science awards, Professor Peter Hunter, Principal Investigator of the MWC and Director of the Bioengineering Institute, was awarded the Rutherford Medal, New Zealand's highest award for scientific achievement. The award was presented by the Minister of Science and Technology Dr. Wayne Mapp.
The award is in recognition of Peter's enormous contribution to the science of biomedical engineering a subject he has pioneered in New Zealand. From its beginnings in 2001, the Bioengineering Institute at Auckland University now boasts 140 staff and postgraduate students. Peter is a Fellow of the Royal Society of New Zealand and the Royal Society of London. This year he was also appointed Chair of the Marsden Fund Council, and won the academic research category of the World Class New Zealand Awards organised by Kea New Zealand and New Zealand Trade and Enterprise. Peter joins two other Rutherford Medal winners in the MWC: Prof. Bill Denny (1998) and Professor Ted Baker (2006).

Royal Society Announcement


Apr 2009: MWC doctoral student wins inaugural fellowship to Cambrige University   

Nicola Jackson has been awarded the inaugural Fremason Roskil Foundation postdoctoral fellowship to Cambridge University organised by the Royal Society of New Zealand Rutherford Foundation.


Apr 2009: MWC student wins place at international symposium   

Zoe Wilson, a MWC doctoral student in organic chemistry, has been selected to attend the 39th St Gallen Symposium in Switzerland.


Feb 2009: Peter Hunter receives KEA award   

Prof. Peter Hunter recognised by the KEA awards as a New Zealand "Tall poppy". Peter received the Science, Technology and Academia award.


Aug 2008 New startup company receives significant funding   

Major funding for commercial development.Profs. Bill Denny and Peter Shepherd have obtained substantial Australian venture funding for the development of PI3 Kinase inhibitors as anti-cancer drugs. Herald story and the video on TV3 business


June 2008 MRC groups receive HRC funding   

MWC success in Health Research Council funding round.Prof. Peter Shepherd, Ted Baker and John Fraser have obtained close to 5 million in the latest HRC round of funding.


Feb 2008 MWC Scientists receive World Class awards   

Two MWC Scientists win New Zealand fist class awards - 11th February 2008. Professor Garth Cooper has been recognised with the Biotechnology award, and Professor Margaret Brimble has been acknowledged with the Research, Science, Technology and Academic award.


Dec 2007 MWC PhD student gets paper published in Science   

Secrets revealed about streptococcal adhesion - 10th December 2007. MWC PhD student HaeJoo Kang's work on the structure of the streptococcal pilus; a hair like adhesion structure that S. pyogenes uses to latch onto host tissue, is published in the prestigious international journal Science. Read the commentary in Science.


Sep 2007 A new tool to predict the spread of melanoma   

A new tool to predict the spread of melanoma - 12th Sept 2007


Sep 2007 Discoveries on immune evasion by Staph aureus   

How superbugs evade the immune system - 12th Sept 2007


Jun 2007 MWC doctoral student in McDiarmid Young Scientist award   

MWC student Peter Brown is runner-up in the Advancing Human Health catergory of the McDiarmid Young Scientist of the Year award - 20th June 2007


MWC receives news of refunding - 5th June 2007

Director Ted Baker awarded the Rutherford Medal - 15th November 2006

Wilken's Centre PhD student honoured with AIMES award - 3rd November 2006.

New clues to treating diabetes Read this story in the NZ Herald - 3rd September 2006.

Minister Opens Maurice Wilkins Centre

Disarming deadly superbug.

Remuera student investigates novel cancer treatment to reduce chemo side effects.

Student seeks to disarm superbug.


Director of the MWC awarded the prestigeous Rutherford Medal, the highest accolade in New Zealand Science   

It was with the greatest pleasure that members of the MWC were present at the Annual Royal Society of New Zealand Science Awards dinner to acknowledge the award of the Rutherford Medal to Professor Ted Baker, Director of the MWC. The Rutherford medal is the highest accolade bestowed on a New Zealand Scientist and is a result of nomination and voting by his/her peers . The award is just recognition of a long and celebrated career in structural biology.


CMB student runner up to MacDiarmid Young Scientist of the Year   

Hayley Reynolds, whose research is funded by the CMB has developed technology that may help doctors to monitor and predict the spread of melanoma in cancer patients using 3D computer models. Her poster won an award in the "Advancing Human Health" section of the national award scheme. Her work was supervised by Dr. Nic Smith and Assoc. Prof. Rod Dunbar.


Prof. Peter Hunter elected to the Royal Society   

It with great pride that we are announce the election of Peter Hunter to the prestigious Fellow of the British Royal Society. Professor Peter Hunter is the only New Zealander among 44 scientists from the United Kingdom and the Commonwealth who have been recognised by the Society this year for their exceptional contributions to science, engineering and medicine.


A new type of anti-cancer drug   

PR104 hypoxia activated cancer drug ready for the clinic.Scientists in the CMB have passed a major milestone with the initial clinical trials of the first hypoxia (low oxygen) activated pro-drug called PR104 to treat solid tumours. This represents the culmination of over 10 years of drug design, development and testing and promises an entirely new way to kill solid tumours from the inside out.


Resources
About Us
Research Profile

Structure based drug design for tuberculosis. Read about Professor Bill Denny and Dr. Brian Palmer who are developing new agents to treat one of man's oldest and most intractable diseases.